Current Search Criteria:
Intervention: Rapamycin, Mitoxantrone, Etoposide, Cytarabine
Found 6 matching trials
Sirolimus in Combination With MEC in High Risk Myeloid Leukemias
PHASE1The purpose of this study is to evaluate the side effects of sirolimus (rap...
Location
University of Pennsylvania Abramson Cancer Center
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
PHASE2This randomized phase II trial is comparing three different combination che...
Location
University of Alabama at Birmingham
Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid Leukemia
PHASE2This pilot phase II trial studies whether biomarkers (biological molecules)...
Location
Thomas Jefferson University
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
NAThis pilot clinical trial studies the feasibility of choosing treatment bas...
Location
Fred Hutch/University of Washington Cancer Consortium
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma
PHASE2Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Location
National Institutes of Health Clinical Center
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML)
NAThe purpose of this study is to evaluate the addition of Sirolimus (rapamyc...
Location
University of Pennsylvania